🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study evaluates inhaled molgramostim (recombinant human granulocyte ma...
Status
Completed
Location
UCLA
Start Date
2016-03-21
Trial ID
NCT02702180
Treatments Being Tested
To assess the safety and tolerability of inhaled molgramostim nebuliser sol...
Status
Completed
Location
Universitätsklinikum Carl Gustav Carus Dresden
Start Date
2020-09-24
Trial ID
NCT04569877
Treatments Being Tested
SAV006-03 is an open-label extension study for participants who had complet...
Status
Terminated
Location
Dept. Of Respiratory Diseases & Allergy
Start Date
2018-04-16
Trial ID
NCT03482752
Treatments Being Tested
Autoimmune pulmonary alveolar proteinosis (aPAP) is a rare disorder in whic...
Status
Available
Location
University of California
Start Date
TBD
Trial ID
NCT06546098
Treatments Being Tested
A study to evaluate the efficacy of inhaled molgramostim administered open-...
Status
Terminated
Location
National Jewish Health
Start Date
2019-06-20
Trial ID
NCT03597347
Treatments Being Tested
This is a randomized, double-blind, placebo-controlled, single ascending (S...
Status
Completed
Location
Celerion
Start Date
2015-05
Trial ID
NCT02468908
Treatments Being Tested
The goal of this open-label study is to study molgramostim as a treatment f...
Status
Recruiting
Location
Ludwig Maximilians Universität München - Dr. von Haunersches Kinderspital - Kinderklinik und Kinderpoliklinik
Start Date
2025-10-22
Trial ID
NCT06431776
Treatments Being Tested
160 subjects with autoimmune pulmonary alveolar proteinosis (aPAP) will be ...
Status
Active Not Recruiting
Location
University Of Arkansas For Medical Services
Start Date
2021-05-19
Trial ID
NCT04544293
Treatments Being Tested